- Home
- EMD vs UROY Comparison
EMD vs UROY Comparison
Compare EMD & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | EMD | UROY |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 613.9M | 513.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EMD | UROY |
|---|---|---|
| Price | $10.88 | $3.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 248.5K | ★ 1.8M |
| Earning Date | 01-01-0001 | 12-11-2025 |
| Dividend Yield | ★ 10.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | N/A | ★ $27,076,881.00 |
| Revenue This Year | N/A | $195.97 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1,370.23 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.85 | $1.43 |
| 52 Week High | $9.55 | $5.37 |
Technical Indicators
Market Signals| Indicator | EMD | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 66.58 | 51.43 |
| Support Level | $10.71 | $3.44 |
| Resistance Level | $10.67 | $3.89 |
| Average True Range (ATR) | 0.12 | 0.21 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 95.24 | 55.12 |
Price Performance
Historical ComparisonAbout EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.